Back to Journals » OncoTargets and Therapy » Volume 8

Original Research

Heme oxygenase-1 is a predictive biomarker for therapeutic targeting of advanced clear cell renal cell carcinoma treated with sorafenib or sunitinib

       
Total article views   HTML views PDF downloads Totals
9,131 Dovepress* 8,526+ 1,294 9,820
PubMed Central* 605 289 894
Totals 9,131 1,583 10,714
*Since 10 August 2015
+Since July 2016

View citations on PubMed Central and Google Scholar